While most people tolerate them well, its helpful to know what side effects to expect, especially in the first few weeks of treatment: nausea vomiting diarrhea constipation headaches fatigue These symptoms are well-documented across clinical trials and often appear during the dose escalation phase
Daily targets: Sodium: 2,500-3,000mg with medical guidance Potassium: 4,700mg or more with medical monitoring Magnesium glycinate: 350mg supplemental (upper limit) Calcium citrate: 1,000-1,200mg supplemental (divided doses) Vitamin D: 2,000 IU daily Oral rehydration solution (ORS): As needed after each episode of fluid loss Implementation: Sip ORS continuously throughout the day Small frequent electrolyte doses rather than large single doses Bone broth as tolerated between meals Magnesium and calcium in divided doses to maximize absorption Daily symptom tracking including fluid intake, urine color, and episodes of vomiting or diarrhea Contact provider if unable to keep fluids down for more than 24 hours If you are on Protocol 3, talk to your healthcare provider about whether a dose adjustment is appropriate
It is not on the Australian Register of Therapeutic Goods
At this time, no
Covers Wegovy (oral $149/mo via Walgreens, injection $349/mo direct), Saxenda (limited), Ozempic and Rybelsus (savings card $25/mo for eligible commercial)
Asked what Zappy is now advising its patients to do with their Ousia vials, Choueiri wrote to NPR: "As always, Zappy is a platform that connects patients to affordable care but does not replace the role of medical providers or pharmacists
